
|Articles|May 9, 2008
Bevacizumab improves success rate of augmented trabeculectomy for neovascular glaucoma in young diabetic patients
The addition of bevacizumab (Avastin) to trabeculectomy improves the success rate of IOP control, particularly in young diabetic patients with neovascular glaucoma (NVG), according to a study published online, ahead of print, by Eye.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
2
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
3
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5











